Reactive arthritis, an HLA-B27 associated disease, is usually triggered by an infection caused by a variety of micro-organisms.' 2 Most of the organisms known to induce reactive arthritis are Gram negative and thus share a common chemical component-lipopolysaccharide (LPS)-in their cell wall. LPS is a potent inflammatory agent causing fever, leucopenia/leucocytosis, activation of the complement and kinin cascades, changes in the coagulation cascade, and also release of prostaglandins and leucotrienes.i9
In vitro, LPS is known to act as an immunomodulator affecting the function of lymphocytes, monocytes, and polymorphonuclear leucocytes (PMNs). 10 The in vivo effects of LPS have been extensively studied in experimental animals. Intra-articularly injected LPS induces joint inflammation with PMN migration and arthralgia. " When administered systemically, LPS has been reported to produce microscopic inflammatory changes in guinea pig joints.12 LPS is also able to induce anterior uveitis in experimental animals. 13 After studying LPS induced uveitis, Rosenbaum proposed that LPS could serve as a common determinant between all the organisms Accepted for publication 14 Louis, Mo, USA) was first dissolved in dimethylsulphoxide, diluted with PBS to lx 10-3 mol/Il and stored at -20°C. The final concentration for daily use was diluted from this stock solution. The concentrations used were: 10-9 mol/l for chemotaxis and chemiluminescence and 2 x 10-9 mol/l for enzyme release assays.
Rabbit C5a was partially purified from yeast activated rabbit serum, as previously described,25 using CM-Sepharose and Sephadex G-100 columns (Pharmacia). The partially purified C5a had optimal chemotactic activity at a protein concentration of 10 ig/ml. The concentrations of C5a used were 0-1% for chemotaxis, 0-2% for enzyme release, and 0*7% or 1-4% for chemiluminescence assays.
Platelet activating factor (PAF; Sigma) was stored in chloroform, 2 mg/ml, at -20°C. For daily experiments chloroform was evaporated under nitrogen and PAF was dissolved in ethanol. This was diluted to the desired concentration with HBSS. In chemiluminescence assays 15 ng/ml of PAF was used.
Leucotriene (LTB4) was stored in ethanol at -70°C. For each experiment, a fresh solution was prepared in HBSS. The concentrations of LTB4 used were 5 ng/ml for chemotaxis, 20 ng/ml for enzyme release, and 15 ng/ml for chemiluminescence assays.
MEASUREMENT OF PMN CHEMOTAXIS PMN migration was assayed using a modified Boyden chamber. 26 The PMN suspension was placed in the upper compartment and the chemoattractants or buffer in the lower compartment separated by a nitrocellulose filter, pore diameter 3 im (Sartorius, Gottingen, FRG). The chambers were incubated at 37°C for 35 minutes. The filters were then stained with Mayer's haematoxylin (Sigma), dehydrated with a rising alcohol concentration, and clarified with xylene. All experiments were performed in duplicate and five fields per filter were examined by the leading front method described by Zigmond and Hirsch.27 Unstimulated migration is the migration of PMNs towards the buffer alone, and chemotaxis is the difference between the unstimulated migration and the migration stimulated by a chemoattractant.
RELEASE OF LYSOSOMAL ENZYMES
Release of the azurophilic granule enzyme 0-glucuronidase was measured with phenolphthalein glucuronic acid (Sigma) as substrate as previously described.22 8 Briefly, PMNs were first incubated with cytochalasin B (1 ,ug/ml; Sigma) at 37°C for 7-5 minutes. The soluble stimuli were added and the incubation continued at 37°C for 15 minutes. The supernatants were collected and the enzyme activity in them measured after an 18 hour incubation with the substrate. Total enzyme activity was determined from lysates of PMNs exposed to 0 1% (v/v) Triton X-100. The non-specific release of enzyme was measured from supernatants of unstimulated PMNs. All the enzyme assays were performed in duplicate. The enzyme activities in the samples are expressed as a percentage of the total enzyme activity after subtracting the non-specific enzyme release. The spontaneous enzyme release during incubation served as a control of cell permeability and varied between 0% and 2-8%.
Release of myeloperoxidase was measured from cell free supernatants similar to those used in the P-glucuronidase experiments. The supernatants were allowed to react with 3-9 mM o-dianisidine (dimethoxybenzene; Sigma) in the presence of H202. The reaction was halted by addition of 1% NaN3. 29 The calculations were performed in a similar way to those in the ,B-glucuronidase experiments.
CHEMILUMINESCENCE ASSAY
The chemiluminescence assays were performed using a Luminometer 1250 (Wallac, Turku, Finland). The cell suspension (0-5 ml) was first incubated at 37°C. After 10 minutes 100 RI of 1 (Fig. 1) . Unstimulated migration of PMNs was increased in the LPS treated rabbits (80.5 (11-2) normal v 96-7 (9.9) LPS treated rabbits, mean (SD) in Rm, p<0-01).
Enzyme release Results for enzyme release closely paralleled those observed in chemotaxis. The release of ,B-glucuronidase and myeloperoxidase induced by C5a and LTB4 was inhibited, whereas the responses to FMLP were not affected (Figs 2 and 3 ).
Chemiluminescence
The luminol induced chemiluminescence from PMNs in the presence of cytochalasin B was measured in response to one synthetic and three endogenous chemotactic stimuli. In the presence of cytochalasin B, which potentiates the chemiluminescence response, only the response to FMLP remained unaltered, and the responses to C5a, LTB4, and PAF were inhibited in LPS treated animals ( Table 1) .
EFFECT OF IN VITRO LPS TREATMENT ON PMN CHEMILUMINESCENCE
To study the direct effects of Y enterocolitica LPS on PMN functions we first tested the ability of this LPS to induce chemiluminescence from PMNs. LPS concentrations up to 1 ,ug/ml were used, and the responses were followed for 20 minutes. Addition of LPS to the suspension of rabbit PMNs did not fThe results are expressed as mean (SD). In many in vitro studies very high concentrations of LPS have been used. For in vitro experiments we selected LPS concentrations based on the theoretical concentration reached in rabbit serum in the in vivo studies. In this study we could detect no effect on PMN function by direct exposure of the cells to LPS. This finding strongly indicates that the profound in vivo effects we observed are caused by the metabolic events following LPS administration, rather than by a direct, isolated effect of LPS itself.
During the arthritic disease an increased migratory function of PMNs in HLA-B27 positive subjects has been described.34 3 In this study only the unstimulated motility was increased following LPS challenge; stimulated motility was selectively inhibited. This finding of PMN inhibition, however, may provide some insight into the initial pathogenesis of reactive arthritis. It can be postulated that during initial infection PMN functions are inhibited by LPS and the proper elimination of the pathogenic organism is disturbed. In genetically predisposed subjects the organism would then persist-for instance, within the intestinal lymphoid tissue- 
